Urokinase (u-PA) and the u-PA receptor: Modulation of in vitro invasiveness of human bladder cancer cell lines

Advances in Experimental Medicine and Biology

Volumn 462, Issue , 1999, Pages 399-412

  Hudson, M A ^a   McReynold, L M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE; UROKINASE RECEPTOR;

ANTIGEN EXPRESSION; BLADDER CANCER; CANCER CELL CULTURE; CANCER INVASION; CONFERENCE PAPER; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING;

RICKETTSIA SP. PAR;

EID: 0033281563     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4737-2_30     Document Type: Conference Paper

References (45)

1. The urokinase/urokinase-receptor system and cancer invasion
2. Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines
3. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor
4. Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness
5. Biology and biochemistry of proteinase tumor invasion
6. Immunologic detection of the cellular receptor for the urokinase plasminogen activator
7. The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue
8. Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies
9. Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression
10. Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer
11. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro
12. Overexpression of a urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line
13. The urokinase receptor is required for human monocyte chemotaxis in vitro
14. Upregulation of urokinase receptor expression on migrating endothelial cells
15. Differential regulation of plasminogen activators by epidermal growth factor in normal and neoplastic human urothelium
16. Induction of urokinase activity and malignant phenotype in bladder carcinoma cells after transfection of the activated Ha-ras oncogene
17. Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder
18. The content of urokinse-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer
19. The content of urokinase-type plasminogen activator and tumor recurrence in superficial bladder cancer
20. Fibrinolytic activity of in vitro cultivated human bladder cancer cell lines
21. The expression of urokinse, its receptor and plasminogen activator inhibitor-I in bladder cancer
22. Urokinase and the urokinase receptor: Association with in vitro invasiveness of human bladder cancer cell lines
23. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens
24. Identification of urokinase-type plasminogen activator receptor in human endothelial cells and its modulation by phorbol myristate acetate
25. Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes
26. A human tissue culture cell line from a transitional cell tumour of the urinary bladder: Growth, chromosome pattern and ulrastructure
27. Established cell line of urinary bldder carcinoma (T24) containing tumor-specific antigen
28. Characterization of a cell line from human transitional cell cancer of the urinary tract
29. The activity of the pyrimidine biosynthetic pathway in MGH-U1 transitional carcinoma cells grown in tissue culture
30. Cellular heterogeneity in a tissue culture cell line derived from a human bladder carcinoma
31. Flow cytometric analysis of the urokinse receptor (uPAR) on tumor cells by fluorescent uPA-ligand or monoclonal antibody#3936
32. The receptor for urokinase-plasminogen activator
33. Use of avidin-biotin-peroxide complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures
34. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas
35. The urokinase receptor: Involvement in cell surface proteolysis and cancer invasion
36. The receptor for urokinase plasminogen activator: Stromal cell involvement in extracellular proteolysis during cancer invasion
37. Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue
38. The role of the urokinase receptor in extracellular matrix degradation by HT29 human colon carinoma cells
39. Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s)
40. Inhibition of urokinase-type plasminogen activator by antibodies: The effect on dissemination of a human tumor in the nude mouse
41. Invasion of connective tissue by human carcinoma cell lines: Requirment for urokinase, urokinse receptor, and interstitial collagenase
42. Modulation of metastatic potential by cell surface urokinase of murine cells
43. Prevention of metastasis by inhibition of the urokinase receptor
44. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines
45. Localization of urokinase-type plasminogen activator receptor on U937 cells: Phorbol ester PMA induces heterogeneity